Cyclin-dependent kinase enzymes (CDKs) are of two types: cell cycle-regulating CDKs that participate in the progression of ...

Researchers developed novel genetic tools to trace, ablate, and manipulate p16^Ink4a+^ senescent cells, revealing their ...

The breakthrough research was conducted by scientists at the Indian Association for the Cultivation of Science (IACS), ...

Scientists have identified a promising new target for cancer treatment by activating a DNA repair enzyme called TDP1, ...

Scientists at the Indian Association for the Cultivation of Science (IACS), Kolkata, an autonomous institute of the ...

The CDK7 inhibitors market is anticipated to experience substantial growth in the coming years. This growth is driven by a rise in cancer diagnoses, promising results from early-phase clinical ...

In a promising development for cancer treatment, researchers have pinpointed a new target by activating a DNA repair enzyme known as Tyrosyl-DNA phosphodiesterase 1 (TDP1).

However, activating phosphorylation of Cdk by CAK appears to be an exception to this trend. In fact, CAK activity remains high throughout the cell cycle and is not regulated by any known cell-cycle ...

This feedback loop leads to an arrest of the cell cycle. For a complete picture of Cyclin Dependent Kinase 7’s drug pipeline, buy the report here. Blending expert knowledge with cutting-edge ...

The Cyclin Dependent Kinase 13 pipeline drugs market research report outlays comprehensive information on the Cyclin Dependent Kinase 13 targeted therapeutics, complete with analysis by indications, ...

The anti-tumour effects of Berberine, which possesses multiple pharmacological activities, have gained significant attention ...